These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19843888)

  • 1. Putting risk prediction in perspective: relative utility curves.
    Baker SG
    J Natl Cancer Inst; 2009 Nov; 101(22):1538-42. PubMed ID: 19843888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.
    Baker SG; Kramer BS
    J Clin Oncol; 2015 Aug; 33(23):2578-80. PubMed ID: 26124476
    [No Abstract]   [Full Text] [Related]  

  • 3. ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models.
    Verbakel JY; Steyerberg EW; Uno H; De Cock B; Wynants L; Collins GS; Van Calster B
    J Clin Epidemiol; 2020 Oct; 126():207-216. PubMed ID: 32712176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating a new marker for risk prediction: decision analysis to the rescue.
    Baker SG; Kramer BS
    Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Risk Prediction with Data Collection Costs: Novel Estimation of Test Tradeoff Curves.
    Baker SG
    Med Decis Making; 2024 Jan; 44(1):53-63. PubMed ID: 37990924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical inference for decision curve analysis, with applications to cataract diagnosis.
    Sande SZ; Li J; D'Agostino R; Yin Wong T; Cheng CY
    Stat Med; 2020 Sep; 39(22):2980-3002. PubMed ID: 32667093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple Decision-Analytic Functions of the AUC for Ruling Out a Risk Prediction Model and an Added Predictor.
    Baker SG
    Med Decis Making; 2018 Feb; 38(2):225-234. PubMed ID: 29025299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-class ROC analysis--a decision theoretic approach under the ideal observer framework.
    He X; Metz CE; Tsui BM; Links JM; Frey EC
    IEEE Trans Med Imaging; 2006 May; 25(5):571-81. PubMed ID: 16689261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves.
    Lee WC; Wu YC
    Medicine (Baltimore); 2016 Jan; 95(2):e2477. PubMed ID: 26765451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.
    Vickers AJ; Cronin AM; Elkin EB; Gonen M
    BMC Med Inform Decis Mak; 2008 Nov; 8():53. PubMed ID: 19036144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Prediction Models for Lung Cancer: A Systematic Review.
    Gray EP; Teare MD; Stevens J; Archer R
    Clin Lung Cancer; 2016 Mar; 17(2):95-106. PubMed ID: 26712102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graphics and statistics for cardiology: clinical prediction rules.
    Woodward M; Tunstall-Pedoe H; Peters SA
    Heart; 2017 Apr; 103(7):538-545. PubMed ID: 28179372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating a new marker for risk prediction using the test tradeoff: an update.
    Baker SG; Van Calster B; Steyerberg EW
    Int J Biostat; 2012 Mar; 8(1):. PubMed ID: 22499728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.
    Kluth LA; Black PC; Bochner BH; Catto J; Lerner SP; Stenzl A; Sylvester R; Vickers AJ; Xylinas E; Shariat SF
    Eur Urol; 2015 Aug; 68(2):238-53. PubMed ID: 25709027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility as a rationale for choosing observer performance assessment paradigms for detection tasks in medical imaging.
    Wunderlich A; Abbey CK
    Med Phys; 2013 Nov; 40(11):111903. PubMed ID: 24320436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.
    Van Calster B; Vickers AJ; Pencina MJ; Baker SG; Timmerman D; Steyerberg EW
    Med Decis Making; 2013 May; 33(4):490-501. PubMed ID: 23313931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.
    Kerr KF; Brown MD; Zhu K; Janes H
    J Clin Oncol; 2016 Jul; 34(21):2534-40. PubMed ID: 27247223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.